Xtant Medical Holdings Inc (XTNT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Xtant Medical Holdings Inc (XTNT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6641
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowrap, orbitalwrap HD, facet stabilization, milled cervical spacers, traditional allografts, hMatrix ADM, hMatrix PR ADM, and sports medicine. It utilizes sterile technology for manufacturing bacterin products. The company offers its products for the treatment of degenerative, traumatic, and deformity conditions for orthopedic and neurological applications. It operates in Louisiana, Maryland, Oregon, Illinois, Delaware, California, Florida, and New York. Xtant Medical is headquartered in Belgrade, Montana, the US.

Xtant Medical Holdings Inc (XTNT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Xtant Medical Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Xtant Medical Holdings Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Xtant Medical Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Xtant Medical Holdings Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Xtant Medical Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Xtant Medical Holdings Inc, Medical Equipment, Deal Details 11
Partnerships 11
Xtant Medical Enters into Licensing Agreement with Sites Medical 11
X-spine Systems Enters into Licensing Agreement with Zimmer Spine 12
Xtant Medical Enters into Distribution Agreement with Curasan 13
Xtant Medical Enters into Distribution Agreement with Pinnacle Spine 14
Xtant Medical Enters into Distribution Agreement with Vivex Biomedical 15
Xtant Medical Enters into Agreement with Montana State University 16
Equity Offering 17
Xtant Medical to Raise up to USD8.2 Million in Rights Offering of Shares 17
Xtant Medical Amends Terms of Rights Offering of Units for USD11.3 Million 18
Bacterin International Raises USD6.5 Million in Public Offering of Shares 20
Bacterin International Completes Private Placement Of Shares For US$4 Million 22
Bacterin International Completes Private Placement Of Shares For US$4.8 Million 23
Xtant Medical Raises USD4.8 Million in Private Placement of Shares 24
Bacterin International Completes Private Placement Of Shares For US$3.9 Million 25
Debt Offering 26
Xtant Medical Raises USD65 Million in Private Placement of Notes 26
Bacterin International Raises USD65 Million in Private Placement of 6% Notes Due 2021 27
Acquisition 28
Bacterin International Acquires X-spine Systems 28
Xtant Medical Holdings Inc – Key Competitors 29
Xtant Medical Holdings Inc – Key Employees 30
Xtant Medical Holdings Inc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Strategy And Business Planning 32
Oct 06, 2017: Xtant Medical Announces Consolidation of Fixation Operations to Montana and Closure of Dayton Facility 32
Financial Announcements 33
Aug 07, 2018: Xtant Medical announces second quarter 2018 financial results 33
May 08, 2018: Xtant Medical Announces First Quarter 2018 Financial Results 35
Apr 02, 2018: Xtant Announces Fourth Quarter and Year End 2017 Financial Results 37
Nov 21, 2017: Xtant Medical Reports Third Quarter 2017 Financial Results 40
Aug 09, 2017: Xtant Medical Reports Second Quarter 2017 Financial Results 42
May 09, 2017: Xtant Medical Reports First Quarter Revenue of $22.1 million, 5% Growth Compared to the Prior Year Period 43
Mar 09, 2017: Xtant Medical Reports Record Fourth Quarter Revenue of $24.5 million, 10% Growth Compared to Prior Year Period 44
Jan 11, 2017: XTNT Announces Preliminary Fourth Quarter and Full Year 2016 Revenue & Adjusted EBITDA 46
Corporate Communications 47
Aug 20, 2018: Xtant Medical appoints Kathie Lenzen as Chief Financial Officer 47
Jul 10, 2018: Xtant Medical Names Kevin Brandt As Chief Commercial Officer 48
Feb 22, 2017: Xtant Medical Announces Appointment of Carl O’Connell to Permanent CEO 49
Jan 23, 2017: Xtant Medical CEO Dan Goldberger announces resignation 50
Product News 51
Oct 25, 2017: Xtant Medical to Feature Product Portfolio at the 2017 North American Spine Society Annual Meeting 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
Xtant Medical Holdings Inc, Medical Equipment, Key Facts, 2017 2
Xtant Medical Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Xtant Medical Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Xtant Medical Holdings Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Xtant Medical Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Xtant Medical Holdings Inc, Deals By Market, 2012 to YTD 2018 9
Xtant Medical Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Xtant Medical Enters into Licensing Agreement with Sites Medical 11
X-spine Systems Enters into Licensing Agreement with Zimmer Spine 12
Xtant Medical Enters into Distribution Agreement with Curasan 13
Xtant Medical Enters into Distribution Agreement with Pinnacle Spine 14
Xtant Medical Enters into Distribution Agreement with Vivex Biomedical 15
Xtant Medical Enters into Agreement with Montana State University 16
Xtant Medical to Raise up to USD8.2 Million in Rights Offering of Shares 17
Xtant Medical Amends Terms of Rights Offering of Units for USD11.3 Million 18
Bacterin International Raises USD6.5 Million in Public Offering of Shares 20
Bacterin International Completes Private Placement Of Shares For US$4 Million 22
Bacterin International Completes Private Placement Of Shares For US$4.8 Million 23
Xtant Medical Raises USD4.8 Million in Private Placement of Shares 24
Bacterin International Completes Private Placement Of Shares For US$3.9 Million 25
Xtant Medical Raises USD65 Million in Private Placement of Notes 26
Bacterin International Raises USD65 Million in Private Placement of 6% Notes Due 2021 27
Bacterin International Acquires X-spine Systems 28
Xtant Medical Holdings Inc, Key Competitors 29
Xtant Medical Holdings Inc, Key Employees 30
Xtant Medical Holdings Inc, Subsidiaries 31

List of Figures
Xtant Medical Holdings Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Xtant Medical Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Xtant Medical Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Xtant Medical Holdings Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Xtant Medical Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Xtant Medical Holdings Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Xtant Medical Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Xtant Medical Holdings Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Xtant Medical Holdings Inc (XTNT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Parkway Properties Inc:企業のM&A・事業提携・投資動向
    Parkway Properties Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Parkway Properties Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Tompkins Financial Corp (TMP):企業の財務・戦略的SWOT分析
    Tompkins Financial Corp (TMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Bombardier Inc:企業の戦略・SWOT・財務情報
    Bombardier Inc - Strategy, SWOT and Corporate Finance Report Summary Bombardier Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Lee Enterprises Inc (LEE):企業の財務・戦略的SWOT分析
    Lee Enterprises Inc (LEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Minesto AB (MINEST):電力:M&Aディール及び事業提携情報
    Summary Minesto AB (Minesto) is a marine energy technology developer. The company offers ervices such as renewable energy solutions, tidal power plants operations and management, power generation, and deep green technology solutions. It also provides control-system design, hydrodynamics, simulation, …
  • Plantronics, Inc. (PLT):企業の財務・戦略的SWOT分析
    Plantronics, Inc. (PLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Qatar Petroleum-石油・ガス分野:企業M&A・提携分析
    Summary Qatar Petroleum (QP) is a state-owned oil and gas company. The company, along with subsidiaries, affiliates and joint ventures, undertake the exploration, drilling, production, storage, transportation, marketing and sale of crude oil, natural gas and gas liquids, liquefied natural gas (LNG), …
  • Genfit SA (GNFT):企業の財務・戦略的SWOT分析
    Summary Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s pipeline products include GFT505, biomarkers, TGFTX1 and TGFTX4. Its TGFTX1 is a research program …
  • Factor Therapeutics Ltd (FTT):医療機器:M&Aディール及び事業提携情報
    Summary Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd, is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic candidate, VF-001 is a targeted growth factor …
  • Helmerich & Payne Inc (HP):企業の財務・戦略的SWOT分析
    Helmerich & Payne Inc (HP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Avon Products, Inc.:企業の戦略・SWOT・財務情報
    Avon Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Avon Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Energizer Holdings, Inc.:戦略・SWOT・企業財務分析
    Energizer Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Energizer Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Rex International Holding Ltd (5WH):企業の財務・戦略的SWOT分析
    Summary Rex International Holding Ltd (Rex International) formerly Rex International Holding Pte Ltd is an independent exploration and production oil company. The company develops oil and gas properties across Singapore. It operates substantial oil and gas exploration concessions in the UAE, Oman, N …
  • Cipla Ltd (CIPLA):企業の財務・戦略的SWOT分析
    Cipla Ltd (CIPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Inner Mongolia Yili Industrial Group Co Ltd
    Inner Mongolia Yili Industrial Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Inner Mongolia Yili Industrial Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Statkraft AS:企業のM&A・事業提携・投資動向
    Statkraft AS - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Statkraft AS Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Sky Metals Ltd (SKY):企業の財務・戦略的SWOT分析
    Summary Sky Metals Ltd (Sky Metals) is an upstream oil and gas company that offers acquisition, exploration, production and development of oil and gas properties in the US. The company holds interests in conventional and unconventional oil and gas projects in Australia. It projects explores for coal …
  • Kedrion SpA-製薬・医療分野:企業M&A・提携分析
    Summary Kedrion SpA (Kedrion) collects and fractionates blood plasma to develop, produce and distribute plasma-derived therapies. The company’s products are used for the treatment of rare and serious disorders such as hemophilia, immune deficiency and neurological disorders. It also offers products …
  • Sun Pharma Advanced Research Company Ltd (SPARC):製薬・医療:M&Aディール及び事業提携情報
    Summary Sun Pharma Advanced Research Company Ltd (SPARC), a subsidiary of Sun Pharmaceutical Industries Ltd, is a bio pharmaceutical clinical research and development service provider. The company develops active pharmaceutical ingredients, formulations and drug delivery technologies for the treatme …
  • Sun Life Hong Kong Limited:企業の戦略・SWOT・財務分析
    Sun Life Hong Kong Limited - Strategy, SWOT and Corporate Finance Report Summary Sun Life Hong Kong Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆